Hu Keli, Qu Yongxia, Yue Yuankun, Boutjdir Mohamed
Molecular and Cellular Cardiology Program, VA New York Harbor Healthcare System, SUNY Downstate Medical Center and NYU School of Medicine, Brooklyn, NY 11209, USA.
Circ Res. 2004 Mar 5;94(4):e32-8. doi: 10.1161/01.RES.0000121566.01778.06. Epub 2004 Feb 12.
Congenital heart block (CHB) is a conduction abnormality characterized by complete atrioventricular (AV) block. CHB affects fetuses and/or newborn of mothers with autoantibodies reactive with ribonucleoproteins 48-kDa SSB/La, 52-kDa SSA/Ro, and 60-kDa SSA/Ro. We recently established animal models of CHB and reported, for the first time, significant sinus bradycardia preceding AV block. This unexpected observation implies that the spectrum of conduction abnormalities extends beyond the AV node to also affect the SA node. To test this hypothesis, we investigated the functional basis of this sinus bradycardia by characterizing the effects of antibodies from mothers with CHB children (positive IgG) on ionic currents that are known to significantly contribute to spontaneous pacing in SA node cells. We recorded L- (I(Ca.L)) and T- (I(Ca.T)) type Ca2+, delayed rectifier K+ (I(K)), hyperpolarization-activated (I(f)) currents, and action potentials (APs) from young rabbit SA node cells. We demonstrated that positive IgG significantly inhibited both I(Ca.T) and I(Ca.L) and induced sinus bradycardia but did not affect I(f) and I(K). Normal IgG from mothers with healthy children did not affect all the currents studied and APs. These results establish that IgG from mothers with CHB children causes substantial inhibition of I(Ca.T) and I(Ca.L), two important pacemaker currents in rabbit SA node cells and point to both I(Ca.T) and I(Ca.L) as major players in the ionic mechanism by which maternal antibodies induce sinus bradycardia in CHB. These novel findings have important clinical significance and suggest that sinus bradycardia may be a potential marker in the detection and prevention of CHB. The full text of this article is available online at http://circres.ahajournals.org
先天性心脏传导阻滞(CHB)是一种以完全性房室(AV)传导阻滞为特征的传导异常。CHB会影响携带与核糖核蛋白48-kDa SSB/La、52-kDa SSA/Ro和60-kDa SSA/Ro发生反应的自身抗体的母亲所孕育的胎儿和/或新生儿。我们最近建立了CHB动物模型,并首次报告了在AV阻滞之前出现显著的窦性心动过缓。这一意外发现表明,传导异常的范围超出了房室结,还会影响窦房结。为了验证这一假设,我们通过研究患有CHB患儿母亲的抗体(阳性IgG)对已知对窦房结细胞自发起搏有显著作用的离子电流的影响,来探究这种窦性心动过缓的功能基础。我们记录了幼兔窦房结细胞的L型(I(Ca.L))和T型(I(Ca.T))Ca2+、延迟整流K+(I(K))、超极化激活(I(f))电流以及动作电位(APs)。我们证明,阳性IgG显著抑制I(Ca.T)和I(Ca.L)并诱发窦性心动过缓,但不影响I(f)和I(K)。来自健康儿童母亲的正常IgG对所有研究的电流和APs均无影响。这些结果表明,患有CHB患儿母亲的IgG会对兔窦房结细胞中的两种重要起搏电流I(Ca.T)和I(Ca.L)产生实质性抑制,并指出I(Ca.T)和I(Ca.L)都是母体抗体在CHB中诱发窦性心动过缓的离子机制中的主要因素。这些新发现具有重要的临床意义,并表明窦性心动过缓可能是CHB检测和预防中的一个潜在标志物。本文全文可在http://circres.ahajournals.org在线获取